Etravirine in treatment-experienced, HIV-1-infected children and adolescents: 48-week safety, efficacy and resistance analysis of the phase II PIANO study

  1. Tudor-Williams, G.
  2. Cahn, P.
  3. Chokephaibulkit, K.
  4. Fourie, J.
  5. Karatzios, C.
  6. Dincq, S.
  7. Opsomer, M.
  8. Kakuda, T.N.
  9. Nijs, S.
  10. Tambuyzer, L.
  11. Tomaka, F.L.
  12. Bologna, R.
  13. João, E.
  14. Pilotto, J.H.
  15. Mussi-Pinhata, M.
  16. Pinto, J.
  17. Lapointe, N.
  18. Faye, A.
  19. Kebaili, K.
  20. Welch, S.
  21. Bernardi, S.
  22. Galli, L.
  23. Giaquinto, C.
  24. Principi, N.
  25. Zuccotti, G.V.
  26. Scherpbier, H.J.
  27. Marques, L.
  28. Soares, I.
  29. Tavares, M.
  30. Acevedo, M.
  31. Duiculescu, D.
  32. Rugina, S.
  33. Latiff, G.H.
  34. Fortuny, C.
  35. Leal, J.A.L.
  36. Navarro, M.
  37. Ramos, J.T.
  38. Chotpitayasunondh, T.
  39. Kosalaraksa, P.
  40. Ruxrungtham, K.
  41. Abadi, J.
  42. Barton, T.
  43. Borkowsy, W.
  44. Chen, J.
  45. Church, J.
  46. Flynn, P.
  47. Rana, S.
  48. Rutstein, R.
  49. Weiner, L.
  50. Show all authors +
Journal:
HIV Medicine

ISSN: 1468-1293,  1464-2662

Year of publication: 2014

Volume: 15

Issue: 9

Pages: 513-524

Type: Article

DOI: 10.1111/HIV.12141 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus